Gynecologic Oncology | Specialty

Dr. Taylor on Treatments in Development for Endometrial Cancer

January 4th 2018

Alexandra Taylor, MD, consultant, clinical oncology, The Royal Marsden Hospital, discusses treatments in development for patients with endometrial cancer.

Dr. Mahantsetty on Unmet Needs in Cervical Cancer

December 29th 2017

Umesh Mahantshetty, MD, MBBS, radiation oncologist, Tata Memorial Hospital, Mumbai, India, discusses unmet needs for patients with cervical cancer.

Dr. Hensley on Lynch Syndrome in Endometrial Cancer

December 28th 2017

Martee L. Hensley, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses Lynch syndrome for patients with endometrial cancer.

Dr. Ledermann on Systemic Treatment for Rare Gynecologic Tumors

December 27th 2017

Jonathan Ledermann, MD, professor of medical oncology, UCL Cancer Institute, London, United Kingdom, discusses systemic treatment for patients with rare gynecologic tumors.

Dr. Taylor on the Current Treatment Landscape for Endometrial Cancer

December 21st 2017

Alexandra Taylor, MD, consultant, clinical oncology, The Royal Marsden Hospital, discusses the current treatment landscape of advanced endometrial cancer.

Cotesting Unlikely to Detect More Cervical Cancers Than HPV Testing Alone

December 20th 2017

Use of both a Pap smear and an HPV test did not identify more cervical cancers than HPV testing alone.

HPV 16/18 Linked to Increased Relapse Risk in Cervical Cancer

December 19th 2017

Persistent HPV 16/18 infection correlated with higher locoregional relapse, overall relapse, and was also associated with early relapses in women with locally advanced cervical cancers treated with radical radiochemotherapy.

Dr. Mahantshetty Discusses Chemoradiation in Cervical Cancer

December 16th 2017

Umesh Mahantshetty, MD, MBBS, radiation oncologist, Tata Memorial Hospital, Mumbai, discusses chemoradiation in patients with cervical cancer.

Study Finds Significant Survival Disparities in HPV-related Cancer

December 9th 2017

Younger patients, women, and white patients with HPV-related cancers had superior survival at 5 years, indicating that increased HPV vaccination and better access to cancer screening and treatment are likely needed to reduce survival disparities

Dr. Haldorsen Discusses the Challenges With Imaging in Endometrial Cancer

November 28th 2017

Ingfrid Haldorsen, MD, University of Bergen, Haukeland University Hospital, discusses the challenges with imaging in endometrial cancer.

Promise on the Horizon in Advanced Endometrial Cancer

November 21st 2017

Alexandra Taylor, MD, discusses the advances with targeted therapies in endometrial cancer, as well as the challenges that still exist in the treatment and management of patients with advanced disease.

Involved Margins, High-Risk HPV Post-Treatment Predict Treatment Failure in Cervical Cancer

November 14th 2017

Results from a systemic review and meta-analysis of data collected from nearly 45,000 women treated for cervical precancer found that high-risk HPV posttreatment was a more accurate predictor of treatment failure than incomplete rescission.

Soft Tissue Sarcoma: An Increasing Number of Options

November 14th 2017

Second-Line Therapy Options: Role of Trabectedin

November 14th 2017

Soft Tissue Sarcoma: Decisions Following Progression

November 14th 2017

Changing Treatment Landscape in Soft Tissue Sarcoma

November 14th 2017

Olaratumab's Role in Soft Tissue Sarcoma

November 14th 2017

Soft Tissue Sarcoma: Selecting Among Frontline Options

November 14th 2017

First-line Options in Soft Tissue Sarcoma

November 14th 2017

Initial Treatment Approach in Soft Tissue Sarcoma

November 14th 2017